MolNFT v1 · #187222 · protein
Crystal structure of SARS-cov-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16
7S5Q: “Crystal structure of SARS-cov-2 B.1.351 variant receptor binding domain in complex with neutralizing…”. X-ray diffraction, 2 ligands (NAG, SO4). MolNFT v1 #187222 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7S5Q
- Type
- protein
- Length
- 1,068 residues
- Chains
- 5
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P0DTC2
- Ligands
- NAG, SO4
Structure
x-ray diffraction · 5 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 198 | — | P0DTC2 |
| B | — | protein | 219 | — | — |
| C | — | protein | 214 | — | — |
| H | — | protein | 225 | — | — |
| L | — | protein | 212 | — | — |
Ligands and binding sites
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains A
- SO4 · Sulfate ion · ion · 11 copies · chains A, B, H, L
- EDO · 1,2-ethanediol · additive · 5 copies · chains A, H, L
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 7S5Q · Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P0DTC2
- Elsewhere: RCSB PDB 7S5Q · PDBe 7S5Q · UniProt P0DTC2
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.